Dr Abigail Martin and Professor Victoria Hutter have secured backing from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia Ventures and part of the Midlands Engine Investment Fund (MEIF), Mercia’s EIS funds and Pioneer Group. The funding will enable their company, ImmuONE, to move into new headquarters in Milton Keynes and new laboratories in Stevenage to meet the growing demand.
At ImmuONE, we believe in fostering the growth and development of young talents in the field of biotechnology. Our commitment to nurturing bright minds extends beyond cutting-edge research; it’s about shaping the future of healthcare by empowering the leaders of tomorrow. We offer secondary school students valuable experiences through initiatives like the Nuffield Research Placements, which allow young people to find out what it’s like to work in a real biotech company and engage in a meaningful scientific project. Today, we’d like to introduce two of our promising students, Beverley Twum and Riqza Shad, who recently embarked on a two-week placement journey with us. Nilab Hydare, pre-clinical scientist at ImmuONE, skillfully led the project and served as a supportive mentor and supervisor to the students. Their guidance and expertise were instrumental in the success of this endeavor. They’ve agreed to share their insights and experiences, offering a glimpse into what they’ve learned at ImmuONE.